Skip to content

Build Better Bones With Exercise

Build Better Bones With Exercise: A Pilot Randomized Controlled Trial of Exercise in Women With Osteoporotic Vertebral Fracture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01761084
Acronym
B3E
Enrollment
141
Registered
2013-01-04
Start date
2013-01-31
Completion date
2016-12-31
Last updated
2019-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporotic Fractures, Spinal Fractures

Keywords

Osteoporosis, Spine fracture, Vertebral fracture, Exercise Interventions, Exercise

Brief summary

The long-term goal of our research team is to conduct a large multicentre study to evaluate whether tailored home exercise can prevent fractures in high-risk individuals. The proposed project will address the feasibility of such a trial, but will also evaluate the effect of exercise on quality of life, posture and many other outcomes important to individuals with vertebral fractures. Physiotherapists will conduct 6 home visits with participants to deliver the intervention (or social visit for controls) using a similar model to previous work by our team and others. The purpose of this pilot study is determining the feasibility of recruitment, retention and adherence of an international multicentre randomized controlled study evaluating the efficacy of thrice-weekly home exercise for one year among women with vertebral fracture. As secondary objectives, the investigators will examine the effects of exercise on function, balance, quality of life, pain, falls and fractures. The primary hypothesis is that the investigators will successfully recruit and retain the target sample, and achieve an adherence rate of 60%.

Detailed description

There is limited data available from which to develop guidelines for safe and effective exercise prescription among individuals with hip or vertebral fractures. The long-term goal of our research team is to conduct a large multi-centre randomized controlled trial (RCT) to investigate whether participating in a thrice-weekly home exercise program for one year can reduce incident fragility fractures among women aged 65 years or older with a history of vertebral fracture compared to no intervention. The current study is a pilot study with the principal objective of determining the feasibility of recruitment, retention and adherence of an international multicentre RCT evaluating the efficacy of thrice-weekly home exercise for one year among women with vertebral fracture. The intervention was developed by experts in exercise prescription based on a rigorous literature review and Cochrane meta-analysis we have conducted. Physiotherapists will conduct 6 home visits with participants to deliver the intervention (or social visit for controls) using a similar model to previous work by our team and others. Secondary outcomes of the pilot study are those hypothesized to be among the causal pathway linking exercise to fracture risk, including lower extremity strength, posture, balance, as well as falls and fractures. Additional secondary outcomes include quality of life, pain, exercise self-efficacy, the cost of the intervention, and the risk of adverse events associated with exercise. The recruitment and retention process will be summarized using a CONSORT flow diagram, and the reporting of results will be in accordance with the CONSORT criteria. Analyses of feasibility objectives will be descriptive or based on estimates with 95% confidence intervals, where feasibility will be assessed relative to criteria defined a priori. Differences in secondary outcomes will be evaluated in intention to treat analyses via independent student T-tests, Chi Square or logistic regression. The Bonferroni method will be used to adjust the level of significance for secondary outcomes so the overall level is alpha=0.05. Even if the larger trial proves not to be feasible, the current trial will be one of the largest exercise studies among a representative group of women with vertebral fracture to date, and will evaluate the feasibility and costs of a comprehensive home exercise program, and its effect on important secondary outcomes. Osteoporosis Canada has defined a need to develop patient resources on exercise and recently announced a shift in priority to individuals with existing fractures; the proposed pilot study is timely and will directly inform these knowledge translation initiatives.

Interventions

BEHAVIORALExercise and behaviour change strategies

1. cardiovascular exercise (e.g., marching, walking) for ≥10 minutes per day 2. postural retraining and balance exercises ≥3 days a week (will be encouraged to do these daily) 3. perform muscle strengthening and balance training exercises ≥ 3 days a week 4. the exercise intervention was developed using the Bone Fit program as a framework (http://www.bonefit.ca/). The physical therapist will tailor exercises and work with participant to integrate them into their day.

Sponsors

Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV
University of Western Ontario, Canada
CollaboratorOTHER
University Health Network, Toronto
CollaboratorOTHER
McMaster University
CollaboratorOTHER
University of Melbourne
CollaboratorOTHER
University of British Columbia
CollaboratorOTHER
University of Waterloo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has a) a known or suspected vertebral fracture of non-traumatic etiology OR b) one of the following: * documented height loss of ≥2cm * historical height loss of ≥6cm * visible hyperkyphosis * age greater than or equal to 65 years of age * able to understand instructions in english * able to give informed consent (no cognitive impairment)

Exclusion criteria

* Current or prior cancer * On dialysis, known liver, kidney or malabsorption disease * Progressive neurological disorder, unable to stand or walk for 10 metres, with/without gait aid or progressive disorder likely to prevent study completion, palliative care. * Current participation in muscle strengthening or similar exercise program ≥ 3 times per week * Uncontrolled hypertension or other contraindications to exercise

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of Recruitment and RetentionMonthly records up to 12 months.Number of participants recruited and retained. Criteria for success = 20 recruited per site and at least 75% retained.
AdherenceMonthly records over 12 monthsNumber of exercise sessions completed relative to prescribed. We will use a diary for participants to self-report adherence.

Secondary

MeasureTime frameDescription
Number of FallersMonthly up to one year.Diary for participants to self-report falls.
Occiput to Wall DistanceBaseline and one year.
Scores on the Short Physical Performance Battery (SPPB)Baseline and one year.The SPPB consists of balance tests (side-by-side, semi-tandem, and tandem standing), gait speed during 4-meter walk test, and the average time taken to rise from a chair with arms folded across chest and sit back down (Five-Times-Sit-to-Stand test), sub-scores of which are added to determine a composite score (0-12), with higher scores indicative of better performance.
Scores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).Baseline and one year.Balance Outcome Measure for Elder Rehabilitation (BOOMER) includes the step test, the Timed Up and Go, the Functional Reach test and the timed static stance feet together eyes closed test. The sub-scores of which are added to create a composite score (0-16), with higher scores indicating better performance.
Quality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Baseline, 6 months and one year.OQLQ scores range 1-7, with higher scores indicate greater quality of life. EQ5D5L VAS scores range 0-100, with higher scores indicating better overall health. VAS pain scores range 0-10, with lower scores indicating less pain.
Scores on Exercise Self-efficacy Scales.Baseline, 6 months and one year.To assess self-efficacy related to engaging in exercise, participants will be asked Over the next 3 months, how confident are you that you can perform exercise on most days of the week? and Over the next 3 months, how confident are you that you can perform exercise on 3 days of the week?. To assess implementation intentions, participants are asked Do you already have concrete plans regarding exercise?. Patients will rate their answers on a scale from 1-5. Higher scores indicate greater exercise self-efficacy.
ProductivityMonthly up to one year.Questionnaire regarding much did the participant's spine fracture(s) or osteoporosis affect their productivity while working? The scale is 0-10, with higher numbers indicating more effect on their work.
Physical ActivityBaseline, 6 months, 12 monthsA modified version of the Short-Form International Physical Activity Questionnaire (IPAQ) will be completed. A subset of participants at the University of Waterloo (St. Mary's General Hospital) will wear an accelerometer for 7 days.
Number of Serious Adverse Events.Monthly up to one year.Defined as death or event that is life-threatening, requires hospitalization or results in disability.
Number of Individuals Screened and Eligible Per Collection Site.over the course of the study (2.29 years)Number of participants randomized out of all participants screened
Score on Short-form Falls Efficacy Scale International (FES-I).Baseline, 6 months and one year.Questionnaire about how concerned the participant is about the possibility of falling during common daily activities. Scores range from 7 (no concern about falling) to 28 (severe concern about falling.
Number of Participants With Multiple FallsMonthly up to 12 months.
Total Number of FallsMonthly up to 12 months.
Value of Direct Medical Resources Per Participant.Accrued costs over 12 months
Value of Non-direct Medical Resources Per Participant.Accrued costs over 12 months
Participant HeightBaseline and one year
Activities of Daily LivingMonthly up to one year0-10 scale about ability to do activities of daily living. Higher scores indicate more difficulty.
Timed Loaded Standing TestBaseline and one yearA physical performance measure of combined trunk and arm endurance.
Location of Vertebral FracturesBaseline and Month 12Any vertebral fracture (Genant Grade 1 or higher) found on x-ray, divided into location groupings of T1-T3, T4-T8, T9-L1, and L2-L5.
Participant WeightBaseline and Month 12
Number of Potentially Eligible Malesover recruitment period
Number of Fractures.Baseline, one year and at report of fracture (monitored monthly for reports).Incident fracture will be a composite outcome of a vertebral fracture or fragility fracture (excluding fractures due to trauma or cancer). A fracture questionnaire will be used to ascertain the occurrence of fractures, the approximate timing and the cause with fracture occurrence, location and severity verified through health record data. Lateral thoracic and lumbar spine x-rays will be performed on participants at baseline (to confirm prevalent vertebral fractures) and follow-up (to identify new fractures). Vertebral fractures will be defined as radiographic presence of ≥25% reduction in anterior, middle or posterior height of a vertebra using the Genant visual semi-quantitative method.

Countries

Canada

Participant flow

Participants by arm

ArmCount
Exercise and Behaviour Change Strategies
The exercise program will include strength training, balance training and cardiovascular exercise that is individually tailored to the participants' abilities. The physical therapist will also implement strategies to assist with behaviour change, such as documenting progress in a log, participating in action planning and coping planning, and using techniques in the spirit of motivational interviewing. Exercise and behaviour change strategies: a)cardiovascular exercise (e.g., marching, walking) for ≥10 minutes per day b)postural retraining and balance exercises ≥3 days a week (will be encouraged to do these daily) c)perform muscle strengthening and balance training exercises ≥ 3 days a week d)the exercise intervention was developed using the Bone Fit program as a framework (http://www.bonefit.ca/). The physical therapist will tailor exercises and work with participant to integrate them into their day.
71
General Health or Social Discussion
Participants in the control group will receive equal attention, but will not be prescribed exercise, or participate in counselling about exercise. The physical therapist will discuss topics related to general health.
70
Total141

Baseline characteristics

CharacteristicExercise and Behaviour Change StrategiesGeneral Health or Social DiscussionTotal
Age, Continuous76 years
STANDARD_DEVIATION 6.4
77 years
STANDARD_DEVIATION 7.28
76 years
STANDARD_DEVIATION 6.85
Sex: Female, Male
Female
71 Participants70 Participants141 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 710 / 70
other
Total, other adverse events
43 / 7134 / 70
serious
Total, serious adverse events
17 / 7112 / 70

Outcome results

Primary

Adherence

Number of exercise sessions completed relative to prescribed. We will use a diary for participants to self-report adherence.

Time frame: Monthly records over 12 months

Population: Only the Exercise Group received the exercise program.

ArmMeasureValue (MEAN)
Exercise and Behaviour Change StrategiesAdherence66 % of weeks meeting adherence threshold
Primary

Feasibility of Recruitment and Retention

Number of participants recruited and retained. Criteria for success = 20 recruited per site and at least 75% retained.

Time frame: Monthly records up to 12 months.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Exercise and Behaviour Change StrategiesFeasibility of Recruitment and Retention66 Participants
General Health or Social DiscussionFeasibility of Recruitment and Retention64 Participants
Secondary

Activities of Daily Living

0-10 scale about ability to do activities of daily living. Higher scores indicate more difficulty.

Time frame: Monthly up to one year

Population: Subsequent number of participants drops after baseline due to withdrawals or monthly follow-up not being completed.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 22.99 units on a scaleStandard Deviation 2.841
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 72.95 units on a scaleStandard Deviation 2.772
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 43.14 units on a scaleStandard Deviation 2.762
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 82.98 units on a scaleStandard Deviation 2.723
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 12.79 units on a scaleStandard Deviation 2.696
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 92.98 units on a scaleStandard Deviation 2.831
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 53.45 units on a scaleStandard Deviation 2.922
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 102.97 units on a scaleStandard Deviation 2.414
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 32.96 units on a scaleStandard Deviation 2.946
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 112.90 units on a scaleStandard Deviation 2.537
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 62.74 units on a scaleStandard Deviation 2.613
Exercise and Behaviour Change StrategiesActivities of Daily LivingMonth 122.52 units on a scaleStandard Deviation 2.599
Exercise and Behaviour Change StrategiesActivities of Daily LivingBaseline3.17 units on a scaleStandard Deviation 3.005
General Health or Social DiscussionActivities of Daily LivingMonth 122.58 units on a scaleStandard Deviation 2.342
General Health or Social DiscussionActivities of Daily LivingBaseline3.46 units on a scaleStandard Deviation 2.406
General Health or Social DiscussionActivities of Daily LivingMonth 12.75 units on a scaleStandard Deviation 2.397
General Health or Social DiscussionActivities of Daily LivingMonth 23.05 units on a scaleStandard Deviation 2.446
General Health or Social DiscussionActivities of Daily LivingMonth 33.12 units on a scaleStandard Deviation 2.362
General Health or Social DiscussionActivities of Daily LivingMonth 43.34 units on a scaleStandard Deviation 2.639
General Health or Social DiscussionActivities of Daily LivingMonth 53.39 units on a scaleStandard Deviation 2.741
General Health or Social DiscussionActivities of Daily LivingMonth 62.95 units on a scaleStandard Deviation 2.673
General Health or Social DiscussionActivities of Daily LivingMonth 73.33 units on a scaleStandard Deviation 2.691
General Health or Social DiscussionActivities of Daily LivingMonth 83.07 units on a scaleStandard Deviation 2.389
General Health or Social DiscussionActivities of Daily LivingMonth 93.28 units on a scaleStandard Deviation 2.821
General Health or Social DiscussionActivities of Daily LivingMonth 103.14 units on a scaleStandard Deviation 2.599
General Health or Social DiscussionActivities of Daily LivingMonth 113.32 units on a scaleStandard Deviation 2.381
Comparison: Month 12 scores.p-value: 0.995% CI: [-0.917, 0.807]t-test, 2 sided
Secondary

Location of Vertebral Fractures

Any vertebral fracture (Genant Grade 1 or higher) found on x-ray, divided into location groupings of T1-T3, T4-T8, T9-L1, and L2-L5.

Time frame: Baseline and Month 12

Population: Withdrawals at 12 months - intervention group (n=5) and control group (n=6). The remainder (9 intervention, 8 control) did not have a second x-ray.

ArmMeasureGroupValue (NUMBER)
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesBaseline T1-T33 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesBaseline T4-T854 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesBaseline T9-L174 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesBaseline L2-L538 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesMonth 12 T1-T33 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesMonth 12 T4-T843 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesMonth 12 T9-L166 Fractures
Exercise and Behaviour Change StrategiesLocation of Vertebral FracturesMonth 12 L2-L534 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesMonth 12 L2-L528 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesBaseline T1-T31 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesMonth 12 T1-T32 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesBaseline T4-T842 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesMonth 12 T9-L176 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesBaseline T9-L188 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesMonth 12 T4-T839 Fractures
General Health or Social DiscussionLocation of Vertebral FracturesBaseline L2-L536 Fractures
Secondary

Number of Fallers

Diary for participants to self-report falls.

Time frame: Monthly up to one year.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Exercise and Behaviour Change StrategiesNumber of Fallers48 Participants
General Health or Social DiscussionNumber of Fallers36 Participants
95% CI: [0.99, 1.74]
Secondary

Number of Fractures.

Incident fracture will be a composite outcome of a vertebral fracture or fragility fracture (excluding fractures due to trauma or cancer). A fracture questionnaire will be used to ascertain the occurrence of fractures, the approximate timing and the cause with fracture occurrence, location and severity verified through health record data. Lateral thoracic and lumbar spine x-rays will be performed on participants at baseline (to confirm prevalent vertebral fractures) and follow-up (to identify new fractures). Vertebral fractures will be defined as radiographic presence of ≥25% reduction in anterior, middle or posterior height of a vertebra using the Genant visual semi-quantitative method.

Time frame: Baseline, one year and at report of fracture (monitored monthly for reports).

ArmMeasureGroupValue (NUMBER)
Exercise and Behaviour Change StrategiesNumber of Fractures.Baseline168 Fractures
Exercise and Behaviour Change StrategiesNumber of Fractures.12 Month Follow-up183 Fractures
General Health or Social DiscussionNumber of Fractures.Baseline163 Fractures
General Health or Social DiscussionNumber of Fractures.12 Month Follow-up178 Fractures
95% CI: [0.58, 1.94]
Secondary

Number of Individuals Screened and Eligible Per Collection Site.

Number of participants randomized out of all participants screened

Time frame: over the course of the study (2.29 years)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Exercise and Behaviour Change StrategiesNumber of Individuals Screened and Eligible Per Collection Site.141 Participants
Secondary

Number of Participants With Multiple Falls

Time frame: Monthly up to 12 months.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Exercise and Behaviour Change StrategiesNumber of Participants With Multiple Falls31 Participants
General Health or Social DiscussionNumber of Participants With Multiple Falls22 Participants
Secondary

Number of Potentially Eligible Males

Time frame: over recruitment period

Population: Total people screened for inclusion

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Exercise and Behaviour Change StrategiesNumber of Potentially Eligible Males308 Participants
Secondary

Number of Serious Adverse Events.

Defined as death or event that is life-threatening, requires hospitalization or results in disability.

Time frame: Monthly up to one year.

ArmMeasureValue (NUMBER)
Exercise and Behaviour Change StrategiesNumber of Serious Adverse Events.18 events
General Health or Social DiscussionNumber of Serious Adverse Events.12 events
Secondary

Occiput to Wall Distance

Time frame: Baseline and one year.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesOcciput to Wall DistanceMonth 125.3 centimetresStandard Deviation 4.4
Exercise and Behaviour Change StrategiesOcciput to Wall DistanceBaseline5.3 centimetresStandard Deviation 4
General Health or Social DiscussionOcciput to Wall DistanceBaseline6.2 centimetresStandard Deviation 4.7
General Health or Social DiscussionOcciput to Wall DistanceMonth 126.1 centimetresStandard Deviation 3.9
Comparison: Baselinep-value: 0.81195% CI: [-0.84, 1.07]t-test, 2 sided
Comparison: Month 12p-value: 0.76595% CI: [-0.8, 1.09]t-test, 2 sided
Secondary

Participant Height

Time frame: Baseline and one year

Population: Withdrawals at 12 months - intervention group (n=5) and control group (n=6). The remainder (5 intervention, 2 control) did not attend the follow-up visit.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesParticipant HeightBaseline156.5 centimetresStandard Deviation 6.4
Exercise and Behaviour Change StrategiesParticipant HeightMonth 12156.4 centimetresStandard Deviation 6.6
General Health or Social DiscussionParticipant HeightBaseline156.1 centimetresStandard Deviation 7.2
General Health or Social DiscussionParticipant HeightMonth 12155.9 centimetresStandard Deviation 7.2
Comparison: Comparison of change from baseline in heightp-value: 0.53695% CI: [-0.28, 0.53]t-test, 2 sided
Secondary

Participant Weight

Time frame: Baseline and Month 12

Population: Withdrawals at 12 months - intervention group (n=5) and control group (n=6). The remainder (7 intervention, 2 control) either did not attend the follow-up visit or did not have access to a scale at the visit.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesParticipant WeightBaseline65.1 kilogramsStandard Deviation 12.8
Exercise and Behaviour Change StrategiesParticipant WeightMonth 1266.1 kilogramsStandard Deviation 13.3
General Health or Social DiscussionParticipant WeightBaseline66.5 kilogramsStandard Deviation 15.4
General Health or Social DiscussionParticipant WeightMonth 1266.6 kilogramsStandard Deviation 15.4
Comparison: Comparison of change from baseline in weightp-value: 0.46195% CI: [-0.25, 0.55]t-test, 2 sided
Secondary

Physical Activity

A modified version of the Short-Form International Physical Activity Questionnaire (IPAQ) will be completed. A subset of participants at the University of Waterloo (St. Mary's General Hospital) will wear an accelerometer for 7 days.

Time frame: Baseline, 6 months, 12 months

Population: Withdrawals at 6 months - intervention group (n=4) and control group (n=5) Withdrawals at 12 months - intervention group (n=5) and control group (n=6)

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesPhysical ActivityBaseline Walking168.8 Minutes per weekStandard Deviation 366
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 6 Walking165.4 Minutes per weekStandard Deviation 120.6
Exercise and Behaviour Change StrategiesPhysical ActivityBaseline Moderate-Vigorous physical activity43.2 Minutes per weekStandard Deviation 138.5
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 12 Strength/Balance physical activity68.4 Minutes per weekStandard Deviation 68.3
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 6 Strength/Balance physical activity80.8 Minutes per weekStandard Deviation 85.8
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 12 Moderate-Vigorous physical activity93.9 Minutes per weekStandard Deviation 225.9
Exercise and Behaviour Change StrategiesPhysical ActivityBaseline Strength/Balance physical activity6.7 Minutes per weekStandard Deviation 17
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 12 Walking161.2 Minutes per weekStandard Deviation 140.7
Exercise and Behaviour Change StrategiesPhysical ActivityMonth 6 Moderate-Vigorous physical activity76.1 Minutes per weekStandard Deviation 143.9
General Health or Social DiscussionPhysical ActivityMonth 12 Walking268.0 Minutes per weekStandard Deviation 342.3
General Health or Social DiscussionPhysical ActivityBaseline Moderate-Vigorous physical activity48.8 Minutes per weekStandard Deviation 156.1
General Health or Social DiscussionPhysical ActivityBaseline Walking194.9 Minutes per weekStandard Deviation 278.3
General Health or Social DiscussionPhysical ActivityMonth 6 Strength/Balance physical activity15.7 Minutes per weekStandard Deviation 36.4
General Health or Social DiscussionPhysical ActivityMonth 6 Moderate-Vigorous physical activity147.3 Minutes per weekStandard Deviation 346
General Health or Social DiscussionPhysical ActivityMonth 6 Walking154.0 Minutes per weekStandard Deviation 161.6
General Health or Social DiscussionPhysical ActivityMonth 12 Strength/Balance physical activity21.1 Minutes per weekStandard Deviation 44.9
General Health or Social DiscussionPhysical ActivityMonth 12 Moderate-Vigorous physical activity128.9 Minutes per weekStandard Deviation 352.3
General Health or Social DiscussionPhysical ActivityBaseline Strength/Balance physical activity6.4 Minutes per weekStandard Deviation 16.8
Comparison: Only Month 6 and Month 12 strength and balance physical activity differences were significant.p-value: <0.0595% CI: [-91.8, -40]t-test, 2 sided
Comparison: Only Month 6 and Month 12 strength and balance physical activity differences were significant.p-value: <0.0595% CI: [-69.8, -28.8]t-test, 2 sided
Secondary

Productivity

Questionnaire regarding much did the participant's spine fracture(s) or osteoporosis affect their productivity while working? The scale is 0-10, with higher numbers indicating more effect on their work.

Time frame: Monthly up to one year.

Population: Only participants who reported working and/or volunteering were asked this question.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesProductivityMonth 31.21 units on a scaleStandard Deviation 2.149
Exercise and Behaviour Change StrategiesProductivityMonth 50.11 units on a scaleStandard Deviation 0.471
Exercise and Behaviour Change StrategiesProductivityMonth 7.80 units on a scaleStandard Deviation 1.781
Exercise and Behaviour Change StrategiesProductivityMonth 60.69 units on a scaleStandard Deviation 1.778
Exercise and Behaviour Change StrategiesProductivityMonth 80.93 units on a scaleStandard Deviation 2.056
Exercise and Behaviour Change StrategiesProductivityMonth 11.60 units on a scaleStandard Deviation 2.257
Exercise and Behaviour Change StrategiesProductivityMonth 91.07 units on a scaleStandard Deviation 2.556
Exercise and Behaviour Change StrategiesProductivityMonth 100.95 units on a scaleStandard Deviation 2.089
Exercise and Behaviour Change StrategiesProductivityMonth 41.00 units on a scaleStandard Deviation 1.91
Exercise and Behaviour Change StrategiesProductivityMonth 110.88 units on a scaleStandard Deviation 2.029
Exercise and Behaviour Change StrategiesProductivityMonth 21.32 units on a scaleStandard Deviation 2.212
Exercise and Behaviour Change StrategiesProductivityMonth 120.76 units on a scaleStandard Deviation 2.022
Exercise and Behaviour Change StrategiesProductivityBaseline1.89 units on a scaleStandard Deviation 2.536
General Health or Social DiscussionProductivityMonth 122.16 units on a scaleStandard Deviation 2.115
General Health or Social DiscussionProductivityBaseline1.85 units on a scaleStandard Deviation 1.927
General Health or Social DiscussionProductivityMonth 22.12 units on a scaleStandard Deviation 1.965
General Health or Social DiscussionProductivityMonth 32.94 units on a scaleStandard Deviation 2.947
General Health or Social DiscussionProductivityMonth 51.57 units on a scaleStandard Deviation 1.91
General Health or Social DiscussionProductivityMonth 61.88 units on a scaleStandard Deviation 2.261
General Health or Social DiscussionProductivityMonth 11.76 units on a scaleStandard Deviation 1.985
General Health or Social DiscussionProductivityMonth 42.50 units on a scaleStandard Deviation 2.307
General Health or Social DiscussionProductivityMonth 72.07 units on a scaleStandard Deviation 2.556
General Health or Social DiscussionProductivityMonth 82.00 units on a scaleStandard Deviation 2.191
General Health or Social DiscussionProductivityMonth 91.76 units on a scaleStandard Deviation 2.333
General Health or Social DiscussionProductivityMonth 101.24 units on a scaleStandard Deviation 1.855
General Health or Social DiscussionProductivityMonth 111.83 units on a scaleStandard Deviation 2.503
Comparison: Baselinep-value: 0.95195% CI: [-1.412, 1.501]t-test, 2 sided
Comparison: Month 12p-value: 0.03995% CI: [-2.721, -0.071]t-test, 2 sided
Secondary

Quality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).

OQLQ scores range 1-7, with higher scores indicate greater quality of life. EQ5D5L VAS scores range 0-100, with higher scores indicating better overall health. VAS pain scores range 0-10, with lower scores indicating less pain.

Time frame: Baseline, 6 months and one year.

Population: Withdrawals at 6 months - intervention group (n=4) and control group (n=5). Withdrawals at 12 months - intervention group (n=5) and control group (n=6).

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Month 65.4 score on a scaleStandard Deviation 1.2
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Month 123.6 score on a scaleStandard Deviation 2.7
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Baseline2.7 score on a scaleStandard Deviation 2.7
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Month 121.9 score on a scaleStandard Deviation 2.2
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Month 675.5 score on a scaleStandard Deviation 17.6
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Baseline3.8 score on a scaleStandard Deviation 2.9
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Month 62.3 score on a scaleStandard Deviation 2.4
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Month 125.4 score on a scaleStandard Deviation 1.4
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Month 1274.6 score on a scaleStandard Deviation 19.1
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Month 63.0 score on a scaleStandard Deviation 2.4
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Baseline5.1 score on a scaleStandard Deviation 1.3
Exercise and Behaviour Change StrategiesQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Baseline74.1 score on a scaleStandard Deviation 19.1
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Baseline5.2 score on a scaleStandard Deviation 1.2
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Baseline75.7 score on a scaleStandard Deviation 20
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Month 65.6 score on a scaleStandard Deviation 1.2
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).OQLQ - Average - Month 125.4 score on a scaleStandard Deviation 1.3
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Baseline2.4 score on a scaleStandard Deviation 2.1
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Month 62.1 score on a scaleStandard Deviation 2.1
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Month 63.5 score on a scaleStandard Deviation 2.5
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Month 123.9 score on a scaleStandard Deviation 2.5
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS at Rest - Month 122.1 score on a scaleStandard Deviation 2.2
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).Pain VAS Movement - Baseline4.2 score on a scaleStandard Deviation 2.6
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Month 675.7 score on a scaleStandard Deviation 18.8
General Health or Social DiscussionQuality of Life (QoL) and Pain Scores Measured Through the EuroQOL Instrument (EQ5D5L) and the Osteoporosis Quality of Life Questionnaire (OQLQ) and a Visual Analog Scale (VAS).EQ5D-VAS - Month 1275.7 score on a scaleStandard Deviation 15.4
Comparison: Comparison of change from baseline in EQ5D - VASp-value: 0.85495% CI: [-5.66, 6.83]t-test, 2 sided
Comparison: Comparison of change from baseline in EQ5D-VASp-value: 0.58595% CI: [-4.66, 8.22]t-test, 2 sided
Comparison: Comparison of change from baseline in OQLQ Average Scorep-value: 0.33595% CI: [-0.16, 0.47]t-test, 2 sided
Comparison: Comparison of change from baseline in OQLQ Average Scorep-value: 0.28595% CI: [-0.15, 0.5]t-test, 2 sided
Comparison: Comparison of change from baseline in pain VAS at restp-value: 0.22595% CI: [-1.36, 0.32]t-test, 2 sided
Comparison: Comparison of change from baseline in pain VAS at restp-value: 0.48895% CI: [-1.16, 0.56]t-test, 2 sided
Comparison: Comparison of change from baseline in pain VAS during movementp-value: 0.80895% CI: [-0.68, 0.88]t-test, 2 sided
Comparison: Comparison of change from baseline in pain VAS during movementp-value: 0.56695% CI: [-0.57, 1.04]t-test, 2 sided
Secondary

Score on Short-form Falls Efficacy Scale International (FES-I).

Questionnaire about how concerned the participant is about the possibility of falling during common daily activities. Scores range from 7 (no concern about falling) to 28 (severe concern about falling.

Time frame: Baseline, 6 months and one year.

Population: Withdrawals at 6 months - intervention group (n=4) and control group (n=5). Withdrawals at 12 months - intervention group (n=5) and control group (n=6).

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesScore on Short-form Falls Efficacy Scale International (FES-I).Baseline12.1 score on a scaleStandard Deviation 4.8
Exercise and Behaviour Change StrategiesScore on Short-form Falls Efficacy Scale International (FES-I).Month 611.4 score on a scaleStandard Deviation 4
Exercise and Behaviour Change StrategiesScore on Short-form Falls Efficacy Scale International (FES-I).Month 1211.5 score on a scaleStandard Deviation 4.7
General Health or Social DiscussionScore on Short-form Falls Efficacy Scale International (FES-I).Month 1212.3 score on a scaleStandard Deviation 5
General Health or Social DiscussionScore on Short-form Falls Efficacy Scale International (FES-I).Baseline12.9 score on a scaleStandard Deviation 5.6
General Health or Social DiscussionScore on Short-form Falls Efficacy Scale International (FES-I).Month 611.5 score on a scaleStandard Deviation 4.7
Secondary

Scores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).

Balance Outcome Measure for Elder Rehabilitation (BOOMER) includes the step test, the Timed Up and Go, the Functional Reach test and the timed static stance feet together eyes closed test. The sub-scores of which are added to create a composite score (0-16), with higher scores indicating better performance.

Time frame: Baseline and one year.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesScores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).Baseline13.5 score on a scaleStandard Deviation 2.2
Exercise and Behaviour Change StrategiesScores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).Month 1213.6 score on a scaleStandard Deviation 2.6
General Health or Social DiscussionScores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).Baseline13.2 score on a scaleStandard Deviation 2
General Health or Social DiscussionScores on Balance Outcome Measure for Elder Rehabilitation (BOOMER).Month 1213.2 score on a scaleStandard Deviation 2.3
Comparison: Baselinep-value: 0.71995% CI: [-0.54, 0.78]t-test, 2 sided
Comparison: Month 12p-value: 0.74595% CI: [-0.56, 0.79]t-test, 2 sided
Secondary

Scores on Exercise Self-efficacy Scales.

To assess self-efficacy related to engaging in exercise, participants will be asked Over the next 3 months, how confident are you that you can perform exercise on most days of the week? and Over the next 3 months, how confident are you that you can perform exercise on 3 days of the week?. To assess implementation intentions, participants are asked Do you already have concrete plans regarding exercise?. Patients will rate their answers on a scale from 1-5. Higher scores indicate greater exercise self-efficacy.

Time frame: Baseline, 6 months and one year.

Population: Withdrawals at 6 months - intervention group (n=4) and control group (n=5). Withdrawals at 12 months - intervention group (n=5) and control group (n=6)

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesScores on Exercise Self-efficacy Scales.Baseline4.4 units on a scaleStandard Deviation 0.7
Exercise and Behaviour Change StrategiesScores on Exercise Self-efficacy Scales.Month 64.2 units on a scaleStandard Deviation 0.7
Exercise and Behaviour Change StrategiesScores on Exercise Self-efficacy Scales.Month 124.0 units on a scaleStandard Deviation 0.8
General Health or Social DiscussionScores on Exercise Self-efficacy Scales.Baseline4.4 units on a scaleStandard Deviation 0.6
General Health or Social DiscussionScores on Exercise Self-efficacy Scales.Month 64.0 units on a scaleStandard Deviation 0.8
General Health or Social DiscussionScores on Exercise Self-efficacy Scales.Month 124.0 units on a scaleStandard Deviation 0.7
Secondary

Scores on the Short Physical Performance Battery (SPPB)

The SPPB consists of balance tests (side-by-side, semi-tandem, and tandem standing), gait speed during 4-meter walk test, and the average time taken to rise from a chair with arms folded across chest and sit back down (Five-Times-Sit-to-Stand test), sub-scores of which are added to determine a composite score (0-12), with higher scores indicative of better performance.

Time frame: Baseline and one year.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesScores on the Short Physical Performance Battery (SPPB)Baseline9.6 score on a scaleStandard Deviation 2.2
Exercise and Behaviour Change StrategiesScores on the Short Physical Performance Battery (SPPB)12 months9.7 score on a scaleStandard Deviation 2.5
General Health or Social DiscussionScores on the Short Physical Performance Battery (SPPB)Baseline8.8 score on a scaleStandard Deviation 2.3
General Health or Social DiscussionScores on the Short Physical Performance Battery (SPPB)12 months9.0 score on a scaleStandard Deviation 2.3
Comparison: Baselinep-value: 0.79695% CI: [-0.8, 0.61]t-test, 2 sided
Comparison: Month 12p-value: 0.88895% CI: [-0.75, 0.65]t-test, 2 sided
Secondary

Timed Loaded Standing Test

A physical performance measure of combined trunk and arm endurance.

Time frame: Baseline and one year

Population: Only participants from the University of Waterloo and the University of Toronto sites assessed.

ArmMeasureGroupValue (MEDIAN)Dispersion
Exercise and Behaviour Change StrategiesTimed Loaded Standing TestMonth 12120 SecondsStandard Deviation 39.9
Exercise and Behaviour Change StrategiesTimed Loaded Standing TestBaseline101.9 SecondsStandard Deviation 39.8
General Health or Social DiscussionTimed Loaded Standing TestBaseline107.5 SecondsStandard Deviation 34.6
General Health or Social DiscussionTimed Loaded Standing TestMonth 12106 SecondsStandard Deviation 37.6
Comparison: Baselinep-value: 0.71295% CI: [-33.6, 23.2]t-test, 2 sided
Comparison: Month 12p-value: 0.695% CI: [-23.3, 39.5]t-test, 1 sided
Secondary

Total Number of Falls

Time frame: Monthly up to 12 months.

ArmMeasureValue (NUMBER)
Exercise and Behaviour Change StrategiesTotal Number of Falls130 Falls
General Health or Social DiscussionTotal Number of Falls127 Falls
Comparison: Negative Binomial Regression.95% CI: [0.58, 1.63]
Secondary

Value of Direct Medical Resources Per Participant.

Time frame: Accrued costs over 12 months

Population: For each resource cost, only participants utilizing the resource are included.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesValue of Direct Medical Resources Per Participant.Medications2127 Dollars (Canadian)Standard Deviation 3579
Exercise and Behaviour Change StrategiesValue of Direct Medical Resources Per Participant.Medical costs related to adverse events1680 Dollars (Canadian)Standard Deviation 3600
Exercise and Behaviour Change StrategiesValue of Direct Medical Resources Per Participant.Physician visits and tests/ procedures829 Dollars (Canadian)Standard Deviation 1033
Exercise and Behaviour Change StrategiesValue of Direct Medical Resources Per Participant.Allied health professional visits301 Dollars (Canadian)Standard Deviation 331
General Health or Social DiscussionValue of Direct Medical Resources Per Participant.Allied health professional visits95 Dollars (Canadian)Standard Deviation 51
General Health or Social DiscussionValue of Direct Medical Resources Per Participant.Medications1823 Dollars (Canadian)Standard Deviation 3063
General Health or Social DiscussionValue of Direct Medical Resources Per Participant.Physician visits and tests/ procedures848 Dollars (Canadian)Standard Deviation 863
General Health or Social DiscussionValue of Direct Medical Resources Per Participant.Medical costs related to adverse events3130 Dollars (Canadian)Standard Deviation 3180
Secondary

Value of Non-direct Medical Resources Per Participant.

Time frame: Accrued costs over 12 months

Population: For each resource cost, only participants utilizing the resource are included.

ArmMeasureGroupValue (MEAN)Dispersion
Exercise and Behaviour Change StrategiesValue of Non-direct Medical Resources Per Participant.Unpaid caregiver time5005 Dollars (Canadian)Standard Deviation 9220
Exercise and Behaviour Change StrategiesValue of Non-direct Medical Resources Per Participant.Lost productivity998 Dollars (Canadian)Standard Deviation 1642
Exercise and Behaviour Change StrategiesValue of Non-direct Medical Resources Per Participant.Out of pocket costs1007 Dollars (Canadian)Standard Deviation 1453
General Health or Social DiscussionValue of Non-direct Medical Resources Per Participant.Unpaid caregiver time4631 Dollars (Canadian)Standard Deviation 8091
General Health or Social DiscussionValue of Non-direct Medical Resources Per Participant.Lost productivity917 Dollars (Canadian)Standard Deviation 1322
General Health or Social DiscussionValue of Non-direct Medical Resources Per Participant.Out of pocket costs872 Dollars (Canadian)Standard Deviation 1250

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026